The international strategy for Alzheimer's disease is called international, but it's not only international: it fosters, of course, Canadian research that is excellent in different areas of the country, because we want to network better in order to get synergy among Montreal, Vancouver, Toronto, Halifax, and all the cities where there is good research on all aspects of Alzheimer's disease.
You're right, it's half a million now. It's going to be 1.2 million in about 10 to 15 years. And to give you figures that are mind-blasting, in about 15 to 20 years the number of people with dementia and Alzheimer's disease in China will equal the population of Canada, around 30 to 35 million people. So this is really a major challenge.
The research is on two fronts, I would say. The first one is to really identify and try to understand what the early markers of Alzheimer's disease are, because at this point there's no curative to offer. So there's lots of research there, and research is at the levels of genomics, biochemistry, and cognitive disorders. There is imaging that can be at the level of these biomarkers, and there are now more and more results that point first to the fact that it's more complex than it appeared to be initially, and that we have to pursue. But I think there's a little bit of light at the end of the tunnel, and we're starting to get some results, although none that are applicable tomorrow morning. Maybe they'll be applicable in five years.
The second front involves trying to strengthen the brain in order to resist the clinical manifestations of Alzheimer's disease for as long as possible. This does not diminish the disease, but makes it shorter. If you can delay by two, three, or even four years by using these lifestyle activities we refer to, then you have a major gain, and this is already available and starting to be implemented.